PharmaResearch Co (XKRX:214450) Cash Flow for Dividends : ₩-7,529 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is PharmaResearch Co Cash Flow for Dividends?

PharmaResearch Co's cash flow for dividends for the three months ended in Mar. 2024 was ₩0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-7,529 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

PharmaResearch Co's quarterly payment of dividends increased from Sep. 2023 (₩0 Mil) to Dec. 2023 (₩-662 Mil) but then declined from Dec. 2023 (₩-662 Mil) to Mar. 2024 (₩0 Mil).

PharmaResearch Co's annual payment of dividends increased from Dec. 2021 (₩-5,030 Mil) to Dec. 2022 (₩-6,316 Mil) and increased from Dec. 2022 (₩-6,316 Mil) to Dec. 2023 (₩-7,529 Mil).

PharmaResearch Co Cash Flow for Dividends Historical Data

The historical data trend for PharmaResearch Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaResearch Co Cash Flow for Dividends Chart

PharmaResearch Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-2,973.43

-2,964.53

-5,029.86

-6,315.55

-7,529.10

PharmaResearch Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Dividends	Get a 7-Day Free Trial															-283.50	-6,584.10	-	-661.50	-

PharmaResearch Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-7,529 Mil.

PharmaResearch Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of PharmaResearch Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaResearch Co (XKRX:214450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaResearch Co Ltd (XKRX:214450) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

74 Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Seongnam, KOR, 463-400

Website

http://www.pr-products.co.kr

PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

PharmaResearch Co (XKRX:214450) Headlines

No Headlines